July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: ComboMATCH treatment trial E4 is testing a new option for patients with advanced solid tumors that progress despite taxane chemotherapyThis study is for patients with solid tumors that are progressing after treatment with taxane therapies
March 23, 2023 March 23, 2023Categories New TrialsThe ComboMATCH precision medicine initiative is getting set to evaluate several new anti-cancer drug combinationsHospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months
September 26, 2022 September 26, 2022Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Fall 2022Summaries of recently reported ECOG-ACRIN research results
June 24, 2021 June 24, 2021Categories EditorialsOngoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment optionEach arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.